www.fdanews.com/articles/138700-losartan-offers-renoprotection-via-serum-uric-acid-reduction

Losartan Offers Renoprotection Via Serum Uric Acid Reduction

July 26, 2011

Findings from the RENAAL study indicate that losartan therapy reduces the serum uric acid levels of patients with Type 2 diabetes and nephropathy.
MedWire News